STAT
APRIL 4, 2025
During an April 2023 inspection at Raptim facilites in Nava Mumbai, India, FDA inspectors found “objectionable conditions” that led them to conclude the company falsified data in testing for multiple subjects and samples across multiple studies, according to a letter sent last week to the pharmaceutical companies.
European Pharmaceutical Review
MARCH 18, 2025
Novo Nordisk has regained full membership with the Association of the British Pharmaceutical Industry (ABPI), following suspension in 2023. This action resulted after the pharmaceutical company made serious breaches of the ABPI Code of Practice in 2021.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JUNE 12, 2025
Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)
European Pharmaceutical Review
FEBRUARY 17, 2025
billion in 2023/24. Under the new Growth and Skills Levy, employers will be able to allocate funds toward a wider range of training initiatives, including modular courses, short-term programmes, and industry-specific certifications, ensuring companies can equip their workforce with the latest skills in a rapidly evolving landscape.
The Checkup by Singlecare
DECEMBER 2, 2024
According to the drug’s manufacturer , Boehringer Ingelheim , 95% of Combivent Respimat prescriptions were covered by commercial insurance, Medicare, or Medicaid in 2023. Many times, yes. However, your out-of-pocket costs depend completely on your specific insurance plan.
European Pharmaceutical Review
FEBRUARY 13, 2025
Based on the new cost estimates, pharmaceutical manufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.
PharmaVoice
JULY 14, 2025
Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from Q&A Need a DTC platform?
Expert insights. Personalized for you.
142 
Let's personalize your content